Ocular immune privilege and ocular melanoma: Parallel universes or immunological plagiarism?

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anterior chamber; Eye; Immune privilege; Stem cells; Uveal melanoma

Indexed keywords

EID: 84873724917     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00148     Document Type: Review

References (131)

1. Aluvihare, V. R., Kallikourdis, M., and Betz,A. G. (2004). Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271.
2. Aluvihare, V. R., Kallikourdis, M., and Betz, A. G. (2005). Tolerance, suppression and the fetal allograft. J. Mol. Med. 83, 88-96.
3. Apte,R. S.,Mayhew,E.,and Niederkorn, J. Y. (1997). Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest. Ophthalmol. Vis. Sci. 38, 1277-1282.
4. Apte, R. S., and Niederkorn, J. Y. (1996). Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156, 2667-2673.
5. Apte, R. S., Sinha, D., Mayhew, E., Wistow, G. J., and Niederkorn, J. Y. (1998). Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160, 5693-5696.
6. Arck, P. C., Ferrick, D. A., SteeleNorwood, D., Croitoru, K., and Clark, D. A. (1997). Murine T cell determination of pregnancy outcome: I. Effects of strain, alphabeta T cell receptor, gammadelta T cell receptor,and gammadelta T cell subsets. Am. J. Reprod. Immunol. 37, 492-502.
7. Arcuri, F., Cintorino, M., Carducci, A., Papa, S., Riparbelli, M. G., Mangioni, S., Di Blasio, A. M., Tosi, P., and Vigano, P. (2006).Humandecidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 131, 175-182.
8. Asherson, G. L., and Stone, S. H. (1965). Selective and specific inhibition of 24 hour skin reactions in the guineapig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology 9, 205-217.
9. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., and Duke, R. C. (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
10. Beutelspacher, S. C., Pillai, R., Watson, M. P., Tan, P. H., Tsang, J., McClure, M. O., George, A. J., and Larkin, D. F. (2006). Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 36, 690-700.
11. Blom, D. J., Goslings, W. R., De WaardSiebinga, I., Luyten, G. P., Claas, F. H.,Gorter,A.,and Jager,M. J. (1997). Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells. J. Interferon Cytokine Res. 17, 695-700.
12. Bonde, S., and Zavazava, N. (2006). Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24, 2192-2201.
13. Bora, N. S., Gobleman, C. L., Atkinson, J. P., Pepose, J. S., and Kaplan, H. J. (1993). Differential expression of the complement regulatory proteins in the human eye. Invest. Ophthalmol. Vis. Sci. 34, 3579-3584.
14. Chen, P. W., Mellon, J. K., Mayhew, E., Wang, S., He, Y. G., Hogan, N., and Niederkorn, J. Y. (2007). Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp. Eye Res. 85, 617-625.
15. Chidgey, A. P., and Boyd, R. L. (2008). Immune privilege for stem cells: not as simple as it looked. Cell Stem Cell 3, 357-358.
16. Cousins, S. W., McCabe, M. M., Danielpour, D., and Streilein, J. W. (1991). Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32, 2201-2211.
17. Crispe, I. N. (2009). The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147-163.
18. Dal Secco, V., Riccioli, A., Padula, F., Ziparo, E., and Filippini, A. (2008). Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma. Biol. Reprod. 78, 234-242.
19. de Waard-Siebinga, I., Hilders, C. G., Hansen, B. E., van Delft, J. L., and Jager, M. J. (1996). HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefes Arch. Clin. Exp. Ophthalmol. 234, 34-42.
20. Ding, H., Wu, X., and Gao, W. (2005). PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Clin. Immunol. 115, 184-191.
21. Ditzian-Kadanoff, R. (1999). Testicularassociated immune deviation and prevention of adjuvant-induced arthritis by three tolerization methods. Scand. J. Immunol. 50, 150-158.
22. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K.,Lennon,V.A.,Celis,E.,and Chen, L. (2002). Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793-800.
23. Donoso, L. A., Shields, J. A., Augsburger, J. J., Orth, D. H., and Johnson, P. (1985). Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum liver enzyme levels and liver scan. Arch. Ophthalmol. 103, 758.
24. D'Orazio, T. J., DeMarco, B. M., Mayhew, E. S., and Niederkorn, J. Y. (1999). Effect of aqueous humor on apoptosis of inflammatory cell types. Invest. Ophthalmol. Vis. Sci. 40, 1418-1426.
25. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein,E.,Mandelboim,O.,Reisner, Y., and Benvenisty, N. (2006). Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221-229.
26. Drukker, M., Katz, G., Urbach, A., Schuldiner,M.,Markel,G.,Itskovitz Eldor, J., Reubinoff, B., Mandelboim, O., and Benvenisty, N. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99, 9864-9869.
27. Einhorn, L. H., Burgess, M. A., and Gottlieb,J.A. (1974). Metastatic patterns of choroidal melanoma. Cancer 34, 1001-1004.
28. Esser, P., Grisanti, S., and Bartz Schmidt, K. (2001). TGF-beta in uveal melanoma. Microsc. Res. Tech. 52, 396-400.
29. Fallarino, F., Luca, G., Calvitti, M., Mancuso, F., Nastruzzi, C., Fioretti, M. C., Grohmann, U., Becchetti, E., Burgevin, A., Kratzer, R., van Endert, P., Boon, L., Puccetti, P., and Calafiore, R. (2009). Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. J. Exp. Med. 206, 2511-2526.
30. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., and Ferrara, G. B. (2002). Tryptophanderived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459-468.
31. Fujisaki, J., Wu, J., Carlson, A. L., Silberstein, L., Putheti, P., Larocca, R., Gao, W., Saito, T. I., Lo Celso, C., Tsuyuzaki, H., Sato, T., Cote, D., Sykes, M., Strom, T. B., Scadden, D. T., and Lin, C. P. (2011). In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216-219.
32. Gao, B., Radaeva, S., and Park, O. (2009). Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol. 86, 513-528.
33. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000). NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583.
34. Goslings, W. R., Blom, D. J., de Waard Siebinga, I., van Beelen, E., Claas, F. H., Jager, M. J., and Gorter, A. (1996). Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas. Invest. Ophthalmol. Vis. Sci. 37, 1884-1891.
35. Goslings, W. R., Prodeus, A. P., Streilein, J. W., Carroll, M. C., Jager, M. J., and Taylor, A. W. (1998). A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest. Ophthalmol. Vis. Sci. 39, 989-995.
36. Granstein, R. D., Staszewski, R., Knisely, T. L., Zeira, E., Nazareno, R., Latina, M., and Albert, D. M. (1990). Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 144, 3021-3027.
37. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., and Ferguson, T. A. (1995). Fas ligandinduced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
38. Haile, S. T., Bosch, J. J., Agu, N. I., Zeender, A. M., Somasundaram, P., Srivastava, M. K., Britting, S., Wolf, J. B., Ksander, B. R., and Ostrand-Rosenberg, S. (2011). Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80. J. Immunol. 186, 6822-6829.
39. He, Y. G., Mayhew, E., Mellon, J., and Niederkorn, J. Y. (2004). Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest. Ophthalmol. Vis. Sci. 45, 4240-4246.
40. Holets, L. M., Carletti, M. Z., Kshirsagar, S. K., Christenson, L. K., and Petroff, M. G. (2009). Differentiation-induced posttranscriptional control of B7-H1 in human trophoblast cells. Placenta 30, 48-55.
41. Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., and Azuma, M. (2006). B7-H1induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177, 5928-5935.
42. Ishitani, A., and Geraghty, D. E. (1992). Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. U.S.A. 89, 3947-3951.
43. Ito, T., Ito, N., Saatoff, M., Hashizume, H., Fukamizu, H., Nickoloff, B. J., Takigawa, M., and Paus, R. (2008). Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J. Invest. Dermatol. 128, 1196-1206.
44. James, E., Chai, J. G., Dewchand, H., Macchiarulo, E., Dazzi, F., and Simpson, E. (2003). Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 102, 388-393.
45. Kang, H., Wu, W. Y., Lo, B. K., Yu, M., Leung, G., Shapiro, J., and McElwee, K. J. (2010). Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J. Invest. Dermatol. 130, 2677-2680.
46. Kaplan, H. J., Stevens, T. R., and Streilein, J. W. (1975). Transplantation immunology of the anterior chamber of the eye. I. An intra-ocular graft-vs-host reaction (immunogenic anterior uveitis). J. Immunol. 115, 800-804.
47. Kaplan, H. J., and Streilein, J. W. (1977). Immune response to immunization via the anterior chamber of the eye. I.F. lymphocyte-induced immune deviation. J. Immunol. 118, 809-814.
48. Kaplan, H. J., and Streilein, J. W. (1978). Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J. Immunol. 120, 689-693.
49. Kinori, M., Kloepper, J. E., and Paus, R. (2011). Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? Invest. Ophthalmol. Vis. Sci. 52, 4447-4458.
50. Kosiewicz, M. M., Alard, P., and Streilein, J. W. (1998). Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFNgamma and induction of TGFbeta and IL-4 production. J. Immunol. 161, 5382-5390.
51. Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., and DeMars, R. (1990). A class I antigen, HLAG, expressed in human trophoblasts. Science 248, 220-223.
52. Ksander, B. R., Rubsamen, P. E., Olsen, K. R., Cousins, S. W., and Streilein, J. W. (1991). Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest. Ophthalmol. Vis. Sci. 32, 3198-3208.
53. Lass, J. H., Walter, E. I., Burris, T. E., Grossniklaus,H. E., Roat,M. I.,Skelnik, D. L., Needham, L., Singer, M., and Medof, M. E. (1990). Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest. Ophthalmol. Vis. Sci. 31, 1136-1148.
54. Le Discorde, M., Moreau, P., Sabatier, P., Legeais, J. M., and Carosella, E. D. (2003). Expression of HLAG in human cornea, an immuneprivileged tissue. Hum. Immunol. 64, 1039-1044.
55. Lee, H. O., Herndon, J. M., Barreiro, R., Griffith, T. S., and Ferguson, T. A. (2002). TRAIL: a mechanism of tumor surveillance in an immune privileged site. J. Immunol. 169, 4739-4744.
56. Lengerova, A., and Vojtiskova, M. (1963). Prolonged survival of syngeneic male skin grafts in parous C57B1 mice. Folia Biol. (Praha) 9, 72-74.
57. Li, H., Ren, J., Dhabuwala, C. B., and Shichi, H. (1997). Immunotolerance induced by intratesticular antigen priming: expression of TGF-beta, Fas and Fas ligand. Ocul. Immunol. Inflamm. 5, 75-84.
58. Li, L., Baroja, M. L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J., and Bhatia, M. (2004a). Human embryonic stem cells possess immuneprivileged properties. Stem Cells 22, 448-456.
59. Li, X., Taylor, S., Zegarelli, B., Shen, S., O'Rourke, J., and Cone, R. E. (2004b). The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. J. Neuroimmunol. 153, 40-49.
60. Ljunggren, H. G., and Karre, K. (1990). In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
61. Ma, D., Luyten, G. P., Luider, T. M., and Niederkorn, J. Y. (1995). Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest. Ophthalmol. Vis. Sci. 36, 435-441.
62. Ma, D., and Niederkorn, J. Y. (1995). Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology 86, 263-269.
63. Malina, H. Z., and Martin, X. D. (1993). Indoleamine 2,3-dioxygenase activity in the aqueous humor, iris/ciliary body, and retina of the bovine eye. Graefes Arch. Clin. Exp. Ophthalmol. 231, 482-486.
64. Medawar, P. B. (1948). Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58-69.
65. Meecham,W. J.,Char,D. H.,and Kaleta Michaels, S. (1992). Infiltrating lymphocytes and antigen expression in uveal melanoma. Ophthalmic Res. 24, 20-26.
66. Meinhardt, A., Bacher, M., McFarlane, J. R., Metz, C. N., Seitz, J., Hedger, M. P., de Kretser, D. M., and Bucala, R. (1996). Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology 137, 5090-5095.
67. Meinhardt, A., and Hedger, M. P. (2011). Immunological, paracrine and endocrine aspects of testicular immune privilege. Mol. Cell. Endocrinol. 335, 60-68.
68. Mellor, A. L., Keskin, D. B., Johnson, T., Chandler, P., and Munn, D. H. (2002). Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J. Immunol. 168, 3771-3776.
69. Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., and Munn, D. H. (2001). Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2, 64-68.
70. Menard, C., Hagege, A. A., Agbulut, O., Barro, M., Morichetti, M. C., Brasselet, C., Bel, A., Messas, E., Bissery, A., Bruneval, P., Desnos, M., Puceat, M., and Menasche, P. (2005). Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366, 1005-1012.
71. Mital, P., Hinton, B. T., and Dufour, J. M. (2011). The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol. Reprod. 84, 851-858.
72. Moffett-King, A. (2002). Natural killer cells and pregnancy. Nat. Rev. Immunol. 2, 656-663.
73. Munn, D. H., Shafizadeh, E., Attwood, J. T.,Bondarev,I.,Pashine,A.,and Mellor, A. L. (1999). Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372.
74. Namba, K., Kitaichi, N., Nishida, T., and Taylor, A. W. (2002). Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J. Leukoc. Biol. 72, 946-952.
75. Nemeth, E., Baird,A. W., and O'Farrelly, C. (2009). Microanatomy of the liver immune system. Semin. Immunopathol. 31, 333-343.
76. Niederkorn, J. Y. (2006). See noevil,hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7, 354-359.
77. Niederkorn, J. Y. (2009). Immune escape mechanisms of intraocular tumors. Prog. Retin. Eye Res. 28, 329-347.
78. Niederkorn, J.Y. (2010)."NK cells in the eye,"in Natural Killer Cells, eds M. T. Lotze and A. W. Thomson (Amsterdam: Academic Press), 385-401.
79. Niederkorn, J. Y., Chiang, E. Y., Ungchusri, T., and Stroynowski, I. (1999). Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 68, 1790-1799.
80. Niederkorn, J. Y., and Stein-Streilein, J. (2010). History and physiology of immune privilege. Ocul. Immunol. Inflamm. 18, 19-23.
81. Nishida, T., and Taylor, A. W. (1999). Specific aqueous humor factors induce activation of regulatory T cells. Invest. Ophthalmol. Vis. Sci. 40, 2268-2274.
82. Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., and Murry, C. E. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21, 1345-1357.
83. Okazaki, T., and Honjo, T. (2007). PD1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19, 813-824.
84. Okuma, Y., Saito, K., O'Connor, A. E., Phillips, D. J., de Kretser, D. M., and Hedger, M. P. (2005). Reciprocal regulation of activin A and inhibin B by interleukin-1 (IL-1) and folliclestimulating hormone (FSH) in rat Sertoli cells in vitro. J. Endocrinol. 185, 99-110.
85. Petroff, M. G. (2005). Immune interactions at the maternal-fetal interface. J. Reprod. Immunol. 68, 1-13.
86. Petroff, M. G., Chen, L., Phillips, T. A., Azzola, D., Sedlmayr, P., and Hunt, J. S. (2003). B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 68, 1496-1504.
87. Repp, A. C., Mayhew, E. S., Apte, S., and Niederkorn, J. Y. (2000). Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J. Immunol. 165, 710-715.
88. Robertson, N. J., Brook, F. A., Gardner, R. L., Cobbold, S. P., Waldmann, H., and Fairchild, P. J. (2007). Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. U.S.A. 104, 20920-20925.
89. Robertson, S. A., Ingman, W. V., O'Leary, S., Sharkey, D. J., and Tremellen, K. P. (2002). Transforming growth factor beta - a mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 57, 109-128.
90. Robertson, S. A., Mau, V. J., Hudson, S. N., and Tremellen, K. P. (1997). Cytokine-leukocyte networks and the establishment of pregnancy. Am. J. Reprod. Immunol. 37, 438-442.
91. Rouas-Freiss, N., Goncalves, R. M., Menier,C.,Dausset,J.,and Carosella, E. D. (1997). Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. U.S.A. 94, 11520-11525.
92. Rouas-Freiss, N., Khalil-Daher, I., Marchal-Bras Goncalves, R., Menier, C., Dausset, J., and Carosella, E. D. (1999). Role of HLA-G in maternalfetal immune tolerance. Transplant. Proc. 31, 724-725.
93. Ryan, A. F., Grendell, R. L., Geraghty, D. E., and Golos, T. G. (2002). A soluble isoform of the rhesus monkey nonclassical MHC class I molecule Mamu-AG is expressed in the placenta and the testis. J. Immunol. 169, 673-683.
94. Ryu,Y. H.,and Kim,J. C. (2007). Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. Invest. Ophthalmol. Vis. Sci. 48, 4148-4152.
95. Saunders, P. A., Hendrycks, V. R., Lidinsky, W. A., and Woods, M. L. (2005). PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur. J. Immunol. 35, 3561-3569.
96. Shen, L., Jin, Y., Freeman, G. J., Sharpe, A. H., and Dana, M. R. (2007). The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J. Immunol. 179, 3672-3679.
97. Singh, A. D., and Topham, A. (2003). Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 110, 956-961.
98. Slukvin, I. I., Watkins, D. I., and Golos, T. G. (1999). Tissue distribution of the mRNA for a rhesus monkey major histocompatibility class Ib molecule,Mamu-AG. Tissue Antigens 53, 282-291.
99. Sohn, J. H., Kaplan, H. J., Suk, H. J., Bora, P. S., and Bora, N. S. (2000a). Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest. Ophthalmol. Vis. Sci. 41, 4195-4202.
100. Sohn, J. H., Kaplan, H. J., Suk, H. J., Bora, P. S., and Bora, N. S. (2000b). Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest. Ophthalmol.Vis. Sci. 41, 3492-3502.
101. Somerset, D. A., Zheng, Y., Kilby, M. D., Sansom, D. M., and Drayson, M. T. (2004). Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112, 38-43.
102. Sonoda, K. H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., and Stein Streilein, J. (2001). NK T cell-derived IL-10 is essential for the differentiation of antigenspecific T regulatory cells in systemic tolerance. J. Immunol. 166, 42-50.
103. Streilein, J. W., and Niederkorn, J. Y. (1981). Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153, 1058-1067.
104. Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J.,Yu, X., and Ferguson, T. A. (1997). CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99, 396-402.
105. Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., Cao, F., Ransohoff, K., Sheikh, A. Y., Haddad, M., Connolly, A. J., Davis, M. M., Robbins, R. C., and Wu, J. C. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. U.S.A. 105, 12991-12996.
106. Taylor, A., and Namba, K. (2001). In vitro induction of CD25 + CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell Biol. 79, 358-367.
107. Taylor, A. W. (2007). Ocular immunosuppressive microenvironment. Chem. Immunol. 92, 71-85.
108. Taylor, A. W., Alard, P., Yee, D. G., and Streilein, J. W. (1997). Aqueous humor induces transforming growth factor-beta (TGF-beta)producing regulatory T-cells. Curr. Eye Res. 16, 900-908.
109. Taylor, A. W., Streilein, J. W., and Cousins, S. W. (1992). Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11, 1199-1206.
110. Taylor, A. W., Streilein, J. W., and Cousins, S. W. (1994a). Alphamelanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1, 188-194.
111. Taylor, A. W., Streilein, J. W., and Cousins, S. W. (1994b). Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153, 1080-1086.
112. Taylor, A. W., and Yee, D. G. (2003). Somatostatin is an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 44, 2644-2649.
113. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., and Opelz, G. (2002). Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenaseexpressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457.
114. Tremellen, K. P., Seamark, R. F., and Robertson, S. A. (1998). Seminal transforming growth factor beta1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. Biol. Reprod. 58, 1217-1225.
115. Uccelli, A., Moretta, L., and Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736.
116. Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., and Van den Eynde, B. J. (2003). Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9, 1269-1274.
117. van Dooremaal, J. C. (1873). Die Entwicklung der in fremden Grund versetzten lebenden Geweba. Albrecht Von Graefes Arch. Ophthalmol. 19, 358-373.
118. Verajankorva, E., Setala, N., Teros, T., Salmi, A. A., and Pollanen, P. (2002). Testicular-associated immune deviation: flushing of the testicular lymph sinusoids induces immunosuppression and inhibits formation of EAE in SJL mice. Scand. J. Immunol. 55, 478-483.
119. Verbik, D. J., Murray, T. G., Tran, J. M., and Ksander, B. R. (1997). Melanomas that develop within the eye inhibit lymphocyte proliferation. Int. J. Cancer 73, 470-478.
120. Vetter, C. S., Lieb, W., Brocker, E. B., and Becker, J. C. (2004). Loss of nonclassical MHC molecules MICA/B expression during progression of uveal melanoma. Br. J. Cancer 91, 1495-1499.
121. Vigano, P., Cintorino, M., Schatz, F., Lockwood, C. J., and Arcuri, F. (2007). The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface. Semin. Immunopathol. 29, 135-150.
122. Wang, S., Boonman, Z. F., Li, H. C., He, Y., Jager, M. J., Toes, R. E., and Niederkorn, J. Y. (2003). Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J. Immunol. 171, 2789-2796.
123. Wang, Y., Goldschneider, I., Foss, D., Wu, D. Y., O'Rourke, J., and Cone, R. E. (1997). Direct thymic involvement in anterior chamberassociated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J. Immunol. 158, 2150-2155.
124. Wang, Y., Goldschneider, I., O'Rourke, J., and Cone, R. E. (2001). Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J. Leukoc. Biol. 69, 741-746.
125. Wilbanks, G. A., and Streilein, J. W. (1990). Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71, 383-389.
126. Wilbanks, G. A., and Streilein, J. W. (1991). Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAIDinducing, cell-associated signal exists in the peripheral blood. J. Immunol. 146, 2610-2617.
127. Wu, D. C., Boyd, A. S., and Wood, K. J. (2008). Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26, 1939-1950.
128. Yamagami, S., Kawashima, H., Tsuru, T., Yamagami, H., Kayagaki, N., Yagita, H., Okumura, K., and Gregerson, D. S. (1997). Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64, 1107-1111.
129. Yang, W., Li, H., Chen, P. W., Alizadeh, H., He, Y., Hogan, R. N., and Niederkorn, J. Y. (2009). PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation. Invest. Ophthalmol. Vis. Sci. 50, 273-280.
130. Yoshida, M., Kezuka, T., and Streilein, J. W. (2000a). Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGFbeta-producing regulatory T cells. Invest. Ophthalmol. Vis. Sci. 41, 3862-3870.
131. Yoshida, M., Takeuchi, M., and Streilein, J. W. (2000b). Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 41, 811-821.